Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AME Study of Pimodivir in Healthy Male Subjects
NCT02448004Phase 1Completed
- Sponsor
- Johnson & Johnson
- Start
- May 2015
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of pimodivir in Influenza A virus infection (IAV), sponsored by Johnson & Johnson. Primary endpoints: Maximum Plasma Concentration, Time to Reach Maximum Concentration and 7 more. Started May 2015; status: completed.
02
Drugs
pimodivir
03
Conditions
Influenza A virus infection (IAV)
Beyond the preview
Go deeper on NCT02448004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02448004.